Cipla JV Gets Process Patent for Stem Cell Drug From Japan – NDTV

LivemintCipla JV Gets Process Patent for Stem Cell Drug From JapanNDTVNew Delhi: Drug major Cipla on Monday said its joint venture firm Stempeutics Research has received a process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). "The new patent
http://blog.zandcell.com/cipla-jv-gets-process-patent-for-stem-cell-drug-from-japan-ndtv/